EXTON, Pa., June 10 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Jefferies 3rd Annual Healthcare Conference on Thursday, June 18, 2009.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 9:00 a.m. (ET). To hear the live webcast of the Kensey Nash presentation go to http://www.wsw.com/webcast/jeff35/knsy/. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Thursday, June 18, 2009.
About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, including sports medicine, spine, and endovascular. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
SOURCE Kensey Nash Corporation
